References
Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Ozaki N (2005) No association of GSK3beta gene (GSK3B) with Japanese schizophrenia. Am J Med Genet B Neuropsychiatr Genet 134B:90–92
Lee KY, Ahn YM, Joo EJ, Jeong SH, Chang JS, Kim SC, Kim YS (2006) No association of two common SNPs at position −1727 A/T, −50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 395:175–178
Meng J, Shi Y, Zhao X, Zhou J, Zheng Y, Tang R, Ma G, Zhu X, He Z, Wang Z, Xu Y, Feng G, He L (2008) No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population. J Psychiatr Res 42:365–370
Olsen L, Hansen T, Jakobsen KD, Djurovic S, Melle I, Agartz I, Hall H, Ullum H, Timm S, Wang AG, Jönsson EG, Andreassen OA, Werge T (2008) The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet 9:39
Scassellati C, Bonvicini C, Perez J, Bocchio-Chiavetto L, Tura GB, Rossi G, Racagni G, Gennarelli M (2004) Association study of −1727 A/T, −50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia. Neuropsychobiology 50:16–20
Souza RP, Romano-Silva MA, Lieberman JA, Meltzer HY, Wong AH, Kennedy JL (2008) Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) 200:177–186
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sand, P.G., Domani, M. & Smesny, S. GSK3B and schizophrenia: a case not closed. Psychopharmacology 208, 333–334 (2010). https://doi.org/10.1007/s00213-009-1728-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-009-1728-8